Butyrate inhibits Staphylococcus aureus-aggravated dermal IL-33 expression and skin inflammation through histone deacetylase inhibition

Atopic dermatitis (AD) is an inflammatory skin disease caused by the disruption of skin barrier, and is dominated by the type 2 immune responses. Patients with AD have a high risk of developing Staphylococcus aureus infection. Interleukin-33 (IL-33), an alarmin, has been implicated in the pathophysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chia-Hui, Lai, Alan Chuan-Ying, Chang, Ya-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228744/
https://www.ncbi.nlm.nih.gov/pubmed/37261337
http://dx.doi.org/10.3389/fimmu.2023.1114699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228744/
https://www.ncbi.nlm.nih.gov/pubmed/37261337
http://dx.doi.org/10.3389/fimmu.2023.1114699

Ejemplares similares